NITEL BETA-50
Description
- Combines Telmisartan 40 mg (ARB) and Metoprolol 50 mg (Beta-Blocker, ER)
- Dual-action mechanism for enhanced blood pressure control
- Reduces heart rate, cardiac output, and peripheral vascular resistance
- Provides 24-hour control with once-daily extended-release dosing
- Lowers the risk of heart attack, stroke, and heart failure
- Effective in managing hypertension with associated cardiovascular risks
- Well-tolerated and supports long-term blood pressure maintenance
Composition
TELMISARTAN-40 MG, METOPROLOL-50 MG
Benefits
NITEL BETA-50 offers a synergistic effect in lowering high blood pressure by targeting both vascular resistance and heart rate. Telmisartan ensures 24-hour vasodilation, while Metoprolol (50 mg extended release) provides consistent beta-blockade for effective cardiac protection. This combination helps reduce the strain on the heart, improves blood circulation, and lowers the likelihood of cardiovascular complications. NITEL BETA-50 is ideal for patients who require stronger beta-blockade along with vascular relaxation for optimal blood pressure control.
Introduction
NITEL BETA-50 is a fixed-dose combination tablet that brings together Telmisartan 40 mg, an angiotensin II receptor blocker (ARB), and Metoprolol Succinate 50 mg (extended release), a beta-blocker. This dual-action therapy is specifically formulated to manage hypertension (high blood pressure) and reduce the risk of cardiovascular events such as heart attacks and strokes. Telmisartan works by relaxing and widening blood vessels, while Metoprolol reduces heart rate and cardiac output. Together, they provide comprehensive blood pressure control and heart protection in patients with moderate to severe hypertension or those with associated heart conditions.
